Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 1
2018 1
2019 1
2020 1
2021 1
2022 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Role of ctDNA in Breast Cancer.
Sant M, Bernat-Peguera A, Felip E, Margelí M. Sant M, et al. Among authors: bernat peguera a. Cancers (Basel). 2022 Jan 9;14(2):310. doi: 10.3390/cancers14020310. Cancers (Basel). 2022. PMID: 35053474 Free PMC article. Review.
SAMHD1 expression modulates innate immune activation and correlates with ovarian cancer prognosis.
Gutiérrez-Chamorro L, Felip E, Bernat-Peguera A, Ezeonwumelu IJ, Teruel I, Martínez-Cardús A, Clotet B, Riveira-Muñoz E, Romeo M, Margelí M, Ballana E. Gutiérrez-Chamorro L, et al. Among authors: bernat peguera a. Front Immunol. 2023 Feb 9;14:1112761. doi: 10.3389/fimmu.2023.1112761. eCollection 2023. Front Immunol. 2023. PMID: 36845138 Free PMC article.
Cancer cell plasticity: Impact on tumor progression and therapy response.
da Silva-Diz V, Lorenzo-Sanz L, Bernat-Peguera A, Lopez-Cerda M, Muñoz P. da Silva-Diz V, et al. Among authors: bernat peguera a. Semin Cancer Biol. 2018 Dec;53:48-58. doi: 10.1016/j.semcancer.2018.08.009. Epub 2018 Aug 18. Semin Cancer Biol. 2018. PMID: 30130663 Review.
FGFR Inhibition Overcomes Resistance to EGFR-targeted Therapy in Epithelial-like Cutaneous Carcinoma.
Bernat-Peguera A, Navarro-Ventura J, Lorenzo-Sanz L, da Silva-Diz V, Bosio M, Palomero L, Penin RM, Pérez Sidelnikova D, Bermejo JO, Taberna M, Vilariño N, Piulats JM, Mesia R, Viñals JM, González-Suárez E, Capella-Gutierrez S, Villanueva A, Viñals F, Muñoz P. Bernat-Peguera A, et al. Clin Cancer Res. 2021 Mar 1;27(5):1491-1504. doi: 10.1158/1078-0432.CCR-20-0232. Epub 2020 Dec 1. Clin Cancer Res. 2021. PMID: 33262138
Efficacy of CT-P6 (trastuzumab biosimilar) versus reference trastuzumab in combination with pertuzumab in HER2-positive early-stage breast cancer: Preclinical and real-life clinical data.
Bernat-Peguera A, Trigueros M, Ferrando-Díez A, Ibáñez C, Bystrup S, Martínez-Cardús A, Margelí M, Martínez-Balibrea E. Bernat-Peguera A, et al. Breast. 2022 Apr;62:1-9. doi: 10.1016/j.breast.2022.01.007. Epub 2022 Jan 19. Breast. 2022. PMID: 35078146 Free PMC article.
Dual inhibition of MEK and PI3Kβ/δ-a potential therapeutic strategy in PTEN-wild-type docetaxel-resistant metastatic prostate cancer.
Ruiz de Porras V, Bernat-Peguera A, Alcon C, Laguia F, Fernández-Saorin M, Jiménez N, Senan-Salinas A, Solé-Blanch C, Feu A, Marín-Aguilera M, Pardo JC, Ochoa-de-Olza M, Montero J, Mellado B, Font A. Ruiz de Porras V, et al. Among authors: bernat peguera a. Front Pharmacol. 2024 Jan 22;15:1331648. doi: 10.3389/fphar.2024.1331648. eCollection 2024. Front Pharmacol. 2024. PMID: 38318136 Free PMC article.
Cancer Stem-like Cells Act via Distinct Signaling Pathways in Promoting Late Stages of Malignant Progression.
da Silva-Diz V, Simón-Extremera P, Bernat-Peguera A, de Sostoa J, Urpí M, Penín RM, Sidelnikova DP, Bermejo O, Viñals JM, Rodolosse A, González-Suárez E, Moruno AG, Pujana MÁ, Esteller M, Villanueva A, Viñals F, Muñoz P. da Silva-Diz V, et al. Among authors: bernat peguera a. Cancer Res. 2016 Mar 1;76(5):1245-59. doi: 10.1158/0008-5472.CAN-15-1631. Epub 2015 Dec 30. Cancer Res. 2016. PMID: 26719534